Andrew Reardon - 30 Nov 2022 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
/s/ Andrew Reardon
Issuer symbol
LGND
Transactions as of
30 Nov 2022
Net transactions value
-$78,222
Form type
4
Filing time
01 Dec 2022, 20:39:07 UTC
Previous filing
07 Nov 2022
Next filing
27 Feb 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability $78,222 -1,073 -8.9% $72.90 10,940 30 Nov 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Chief Legal Officer and Secretary